Tivity Health Inc (TVTY) Expected to Announce Quarterly Sales of $152.59 Million

Wall Street analysts forecast that Tivity Health Inc (NASDAQ:TVTY) will announce sales of $152.59 million for the current quarter, Zacks reports. Six analysts have issued estimates for Tivity Health’s earnings. The lowest sales estimate is $151.42 million and the highest is $153.50 million. Tivity Health reported sales of $138.91 million during the same quarter last year, which indicates a positive year-over-year growth rate of 9.8%. The firm is scheduled to announce its next quarterly earnings report on Thursday, July 26th.

According to Zacks, analysts expect that Tivity Health will report full-year sales of $613.51 million for the current fiscal year, with estimates ranging from $609.60 million to $617.90 million. For the next fiscal year, analysts forecast that the firm will post sales of $671.83 million per share, with estimates ranging from $649.79 million to $684.80 million. Zacks’ sales averages are an average based on a survey of research firms that cover Tivity Health.

Tivity Health (NASDAQ:TVTY) last issued its earnings results on Monday, April 23rd. The company reported $0.49 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.49. The firm had revenue of $149.90 million during the quarter, compared to analyst estimates of $154.32 million. Tivity Health had a net margin of 12.33% and a return on equity of 28.62%. The business’s revenue was up 6.3% on a year-over-year basis. During the same period in the previous year, the firm earned $0.42 earnings per share.



TVTY has been the subject of several recent research reports. Piper Jaffray Companies restated a “buy” rating and issued a $49.00 price objective on shares of Tivity Health in a report on Tuesday, April 24th. Chardan Capital reiterated a “neutral” rating and issued a $41.00 target price (down from $44.00) on shares of Tivity Health in a report on Friday, February 23rd. Zacks Investment Research downgraded shares of Tivity Health from a “buy” rating to a “hold” rating in a report on Thursday, April 26th. ValuEngine downgraded shares of Tivity Health from a “hold” rating to a “sell” rating in a report on Saturday, June 2nd. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $53.00 target price on shares of Tivity Health in a report on Friday, February 23rd. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and eight have issued a buy rating to the stock. Tivity Health currently has a consensus rating of “Buy” and a consensus target price of $47.22.

Shares of TVTY stock traded up $0.27 on Friday, hitting $34.43. The stock had a trading volume of 695,747 shares, compared to its average volume of 758,738. The company has a market capitalization of $1.37 billion, a P/E ratio of 20.49, a PEG ratio of 1.45 and a beta of 0.31. Tivity Health has a one year low of $29.95 and a one year high of $48.50.

In other news, CEO Donato Tramuto sold 20,000 shares of the business’s stock in a transaction dated Tuesday, May 1st. The stock was sold at an average price of $35.37, for a total transaction of $707,400.00. Following the sale, the chief executive officer now owns 149,596 shares in the company, valued at $5,291,210.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 8.42% of the stock is currently owned by insiders.

Several hedge funds have recently modified their holdings of the company. Schwab Charles Investment Management Inc. boosted its position in Tivity Health by 27.3% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 200,871 shares of the company’s stock valued at $7,342,000 after buying an additional 43,099 shares during the last quarter. US Bancorp DE boosted its position in Tivity Health by 6.0% in the fourth quarter. US Bancorp DE now owns 27,823 shares of the company’s stock valued at $1,017,000 after buying an additional 1,578 shares during the last quarter. American Century Companies Inc. boosted its position in Tivity Health by 390.7% in the fourth quarter. American Century Companies Inc. now owns 1,238,336 shares of the company’s stock valued at $45,261,000 after buying an additional 985,996 shares during the last quarter. Crossmark Global Holdings Inc. boosted its position in Tivity Health by 49.7% in the fourth quarter. Crossmark Global Holdings Inc. now owns 10,246 shares of the company’s stock valued at $374,000 after buying an additional 3,403 shares during the last quarter. Finally, Teacher Retirement System of Texas purchased a new stake in Tivity Health in the fourth quarter valued at approximately $437,000.

About Tivity Health

Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement, and group retiree plans; and Prime fitness, a fitness facility access program through commercial health plans and employers.

Get a free copy of the Zacks research report on Tivity Health (TVTY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply